Sgarbossa's criteria

From WikiMD's Food, Medicine & Wellness Encyclopedia

Sgarbossa's Criteria are a set of electrocardiographic (ECG) findings used to identify myocardial infarction (also known as a heart attack) in patients with ventricular paced rhythms or existing bundle branch block. These criteria were developed by Dr. Elena B. Sgarbossa in the 1990s and have since been an essential tool in the diagnosis of myocardial infarction in the presence of left bundle branch block (LBBB) or a paced rhythm, situations where the diagnosis of myocardial infarction can be challenging due to the underlying abnormalities in the ECG.

Background[edit | edit source]

Myocardial infarction is a medical condition that occurs when blood flow to a part of the heart is blocked for a long enough time that part of the heart muscle is damaged or dies. The diagnosis is typically made by an ECG, which can show changes indicative of a heart attack. However, in patients with LBBB or those with a pacemaker, the ECG changes due to the infarction can be masked by the underlying rhythm. This makes the diagnosis of myocardial infarction challenging in these patients.

Sgarbossa's Criteria[edit | edit source]

Sgarbossa's Criteria consist of three main components, each of which is assigned a certain number of points. The total score can help determine the likelihood of a myocardial infarction.

Criteria[edit | edit source]

  1. ST-segment elevation ≥ 1 mm in a lead with a positive QRS complex (5 points): This criterion recognizes that ST-segment elevation, when in the same direction as the main QRS complex, is likely pathological.
  2. ST-segment depression ≥ 1 mm in lead V1, V2, or V3 (3 points): ST-segment depression in these anterior leads is significant, especially when considering the location of the infarction.
  3. ST-segment elevation ≥ 5 mm in a lead with a negative QRS complex (2 points): This criterion acknowledges that some ST-segment elevation may be a normal variant in the presence of a negative QRS complex, but an elevation of 5 mm or more is likely indicative of pathology.

A total score of ≥3 has been suggested to indicate a high likelihood of myocardial infarction.

Modification and Use[edit | edit source]

The original criteria have been modified and expanded upon over the years. One significant modification is the addition of the Smith-modified Sgarbossa criteria, which replaces the third criterion with a more nuanced approach based on the ratio of ST-segment elevation to the depth of the S wave in leads with a negative QRS complex.

Sgarbossa's Criteria are used in conjunction with clinical findings and other diagnostic tests to diagnose myocardial infarction in patients with LBBB or a paced rhythm. They are particularly useful in emergency settings where rapid diagnosis and treatment are critical.

Limitations[edit | edit source]

While Sgarbossa's Criteria are a valuable tool, they are not without limitations. The criteria may not detect all cases of myocardial infarction, especially in early stages or in cases with minimal ECG changes. Additionally, the criteria require careful interpretation by experienced clinicians, as misinterpretation can lead to incorrect diagnoses.

Conclusion[edit | edit source]

Sgarbossa's Criteria have significantly improved the ability to diagnose myocardial infarction in patients with LBBB or paced rhythms. Despite their limitations, these criteria remain a crucial part of the diagnostic toolkit for clinicians, particularly in emergency medicine.

‎ ‎


Wiki.png

Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Search WikiMD


Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro) available.
Advertise on WikiMD

WikiMD is not a substitute for professional medical advice. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.


Contributors: Admin, Prab R. Tumpati, MD